Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001415889-25-016319

Director acquired 15,706 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Imper Vera Director 2025-06-05 Option exercise +15,706 15,706 D
Derivatives
Imper Vera Director 2025-06-05 Option exercise · Restricted Stock Units −15,706 0 D
Loading xslF345X05/form4-06092025_090626.xml…